Literature DB >> 9070663

Structural definition of a potent macrophage activating factor derived from vitamin D3-binding protein with adjuvant activity for antibody production.

N Yamamoto1.   

Abstract

Incubation of human vitamin D3-binding protein (Gc protein), with a mixture of immobilized beta-galactosidase and sialidase, efficiently generated a potent macrophage activating factor, a protein with N-acetylgalactosamine as the remaining sugar. Stepwise incubation of Gc protein with immobilized beta-galactosidase and sialidase, and isolation of the intermediates with immobilized lectins, revealed that either sequence of hydrolysis of Gc glycoprotein by these glycosidases yields the macrophage-activating factor, implying that Gc protein carries a trisaccharide composed of N-acetylgalactosamine and dibranched galactose and sialic acid termini. A 3 hr incubation of mouse peritoneal macrophages with picomolar amounts of the enzymatically generated macrophage-activating factor (GcMAF) resulted in a greatly enhanced phagocytic activity. Administration of a minute amount (10-50 pg/mouse) of GcMAF resulted in a seven- to nine-fold enhanced phagocytic activity of macrophages. Injection of sheep red blood cells (SRBC) along with GcMAF into mice produced a large number of anti-SRBC antibody secreting splenic cells in 2-4 days.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9070663     DOI: 10.1016/s0161-5890(96)00081-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

1.  Population studies of intact vitamin D binding protein by affinity capture ESI-TOF-MS.

Authors:  Chad R Borges; Jason W Jarvis; Paul E Oran; Stephen P Rogers; Randall W Nelson
Journal:  J Biomol Tech       Date:  2008-07

Review 2.  Vitamin D and the intracrinology of innate immunity.

Authors:  Martin Hewison
Journal:  Mol Cell Endocrinol       Date:  2010-02-13       Impact factor: 4.102

Review 3.  Combination approaches to potentiate immune response after photodynamic therapy for cancer.

Authors:  Tyler G St Denis; Kanza Aziz; Anam A Waheed; Ying-Ying Huang; Sulbha K Sharma; Pawel Mroz; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2011-04-09       Impact factor: 3.982

4.  Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.

Authors:  Yukiyo Toyohara; Susumu Hashitani; Hiromitsu Kishimoto; Kazuma Noguchi; Nobuto Yamamoto; Masahiro Urade
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

5.  Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells.

Authors:  Kalvin J Gregory; Bing Zhao; Diane R Bielenberg; Sami Dridi; Jason Wu; Weihua Jiang; Bin Huang; Steven Pirie-Shepherd; Michael Fannon
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

6.  Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.

Authors:  Sasha M Daskalova; Josiah E Radder; Zbigniew A Cichacz; Sam H Olsen; George Tsaprailis; Hugh Mason; Linda C Lopez
Journal:  BMC Biotechnol       Date:  2010-08-24       Impact factor: 2.563

7.  Glycosylation status of vitamin D binding protein in cancer patients.

Authors:  Douglas S Rehder; Randall W Nelson; Chad R Borges
Journal:  Protein Sci       Date:  2009-10       Impact factor: 6.725

8.  Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.

Authors:  Nobuto Yamamoto; Hirofumi Suyama; Nobuyuki Yamamoto
Journal:  Transl Oncol       Date:  2008-07       Impact factor: 4.243

Review 9.  Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.

Authors:  Ehsan Saburi; Amin Saburi; Mostafa Ghanei
Journal:  Caspian J Intern Med       Date:  2017

10.  A bone substitute with high affinity for vitamin D-binding protein--relationship with niche of osteoclasts.

Authors:  Tohru Ikeda; Michiyuki Kasai; Eri Tatsukawa; Masanobu Kamitakahara; Yasuaki Shibata; Taishi Yokoi; Takayuki K Nemoto; Koji Ioku
Journal:  J Cell Mol Med       Date:  2013-11-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.